Northern Trust
IMVT icon

Northern Trust’s Immunovant IMVT Stock Holding History

Northern Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.6M Buy
794,004
+121,230
+18% +$3.69M ﹤0.01% 1540
2026
Q1 		$16.7M Buy
672,774
+106,626
+19% +$2.76M ﹤0.01% 1785
2025
Q4 		$14.4M Buy
566,148
+10,233
+2% +$228K ﹤0.01% 1887
2025
Q3 		$8.96M Sell
555,915
-19,468
-3% -$315K ﹤0.01% 2177
2025
Q2 		$9.21M Buy
575,383
+38,761
+7% +$586K ﹤0.01% 2123
2025
Q1 		$9.17M Buy
536,622
+9,255
+2% +$194K ﹤0.01% 2087
2024
Q4 		$13.1M Buy
527,367
+20,377
+4% +$578K ﹤0.01% 1967
2024
Q3 		$14.5M Buy
506,990
+43,269
+9% +$1.28M ﹤0.01% 1832
2024
Q2 		$12.2M Sell
463,721
-14,986
-3% -$426K ﹤0.01% 1878
2024
Q1 		$15.5M Sell
478,707
-15,987
-3% -$583K ﹤0.01% 1771
2023
Q4 		$20.8M Buy
494,694
+15,326
+3% +$564K ﹤0.01% 1590
2023
Q3 		$18.4M Sell
479,368
-13,492
-3% -$305K ﹤0.01% 1602
2023
Q2 		$9.35M Buy
492,860
+81,813
+20% +$1.53M ﹤0.01% 2113
2023
Q1 		$6.38M Sell
411,047
-6,896
-2% -$120K ﹤0.01% 2308
2022
Q4 		$7.42M Buy
417,943
+68,068
+19% +$857K ﹤0.01% 2215
2022
Q3 		$1.95M Sell
349,875
-7,366
-2% -$36K ﹤0.01% 3024
2022
Q2 		$1.39M Sell
357,241
-11,245
-3% -$48.6K ﹤0.01% 3235
2022
Q1 		$2.03M Sell
368,486
-20,910
-5% -$130K ﹤0.01% 3094
2021
Q4 		$3.32M Sell
389,396
-1,649
-0.4% -$13.6K ﹤0.01% 2953
2021
Q3 		$3.4M Sell
391,045
-26,265
-6% -$237K ﹤0.01% 2985
2021
Q2 		$4.41M Sell
417,310
-32,341
-7% -$452K ﹤0.01% 2917
2021
Q1 		$7.21M Sell
449,651
-17,187
-4% -$453K ﹤0.01% 2513
2020
Q4 		$21.6M Buy
466,838
+37,807
+9% +$1.75M ﹤0.01% 1736
2020
Q3 		$15.1M Buy
429,031
+155,699
+57% +$4.68M ﹤0.01% 1835
2020
Q2 		$6.66M Buy
273,332
+251,701
+1,164% +$5.39M ﹤0.01% 2350
2020
Q1 		$337K Sell
21,631
-1,943
-8% -$29.2K ﹤0.01% 3547
2019
Q4 		$374K Buy
+23,574
New +$264K ﹤0.01% 3628

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's IMVT Position: Q2 2026 in Review

Northern Trust increased its Immunovant (IMVT) stake by 18% in Q2 2026, buying an estimated $3.69M and bringing the position to 794,004 shares worth $30.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Northern Trust first reported a position in IMVT in Q4 2019 and has held it in 27 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Northern Trust held 794,004 shares of Immunovant worth $30.6M as of Q2 2026.
  • Northern Trust bought 121,230 Immunovant shares in Q2 2026, an estimated $3.69M.
  • Immunovant made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1540 holding.
  • Northern Trust first reported a position in Immunovant in Q4 2019 and has held it in 27 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.